Natural Product: NPC579039

Natural Product IDNPC579039
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
5-hydroxy-6,8-dimethoxy-2-(4-methoxyphenyl)-7-[(2~{S},3~{R},4~{S},5~{S},6~{R})-3,4,5-trihydroxy-6-[[(2~{R},3~{S},4~{R},5~{R},6~{S})-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
IUPAC Name 5-hydroxy-6,8-dimethoxy-2-(4-methoxyphenyl)-7-[(2~{S},3~{R},4~{S},5~{S},6~{R})-3,4,5-trihydroxy-6-[[(2~{R},3~{S},4~{R},5~{R},6~{S})-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey PAOUJIVFERPFRF-QRLVZTGASA-N
Standard InCHI InChI=1S/C30H36O16/c1-11-18(32)21(35)23(37)29(43-11)42-10-16-19(33)22(36)24(38)30(45-16)46-28-26(40-3)20(34)17-14(31)9-15(44-25(17)27(28)41-4)12-5-7-13(39-2)8-6-12/h5-9,11,16,18-19,21-24,29-30,32-38H,10H2,1-4H3/t11-,16+,18-,19+,21+,22-,23-,24+,29+,30-/m0/s1
SMILES COC1=CC=C(C2=CC(=O)C3=C(O)C(OC)=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C(OC)=C3O2)C=C1

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   652.2 Volume:   604.206
?
Van der Waals volume.
Dense:   1.079 LogP:   0.918
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.48
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.378
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   30.0
TPSA:   236.43
?
Topological Polar Surface Area.
H-Bond Acceptor:   16.0
H-Bond Donor:   7.0 Rings:   5.0
Heavy Atoms:   16.0

MedChem Properties

QED Drug-Likeness Score:   0.15 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.791 Fsp3:   0.5
MCE-18:   120.556
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.536 Fluc inhibitor:   0.251
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.707
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.643
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.034 Promiscuous compounds:   0.247

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.13 MDCK Permeability:   -5.348
Pgp-inhibitor:   0.0 Pgp-substrate:   0.811
PAMPA:   0.997
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.924
20% Bioavailability (F20%):   0.331 30% Bioavailability (F30%):   0.949
50% Bioavailability (F50%):   0.992

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.004 MRP1:   0.605
Plasma Protein Binding (PPB):   87.994% Volume Distribution (VD):   -0.164
Fu: 11.498%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.995
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.073
BSEP inhibitor:   0.013

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.004
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.396
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.164
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.465 Half-life (T1/2):  3.581

ADMET: Toxicity

hERG Blockers:  0.02 hERG Blockers (10um):  0.113
Human Hepatotoxicity (H-HT):  0.496 Drug-induced Liver Injury (DILI):  0.985
AMES Toxicity:  0.915 Rat Oral Acute Toxicity:  0.013
Maximum Recommended Daily Dose:  0.04 Skin Sensitization:  0.985
Carcinogencity:  0.159 Eye Corrosion:  0.0
Eye Irritation:  0.026 Respiratory Toxicity:  0.013
Drug-induced Neurotoxicity:  0.005 Ototoxicity:  0.931
Hematotoxicity:  0.42 Drug-induced Nephrotoxicity:  0.771
Genotoxicity:  0.641 RPMI-8226 Immunitoxicity:  0.38
A549 Cytotoxicity:  0.53 Hek293 Cytotoxicity:  0.541
BCF:   0.322
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.141
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.691
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.856
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26817 Lysionotus pauciflorus Species Gesneriaceae Eukaryota n.a. n.a. n.a. PMID[21775221]
NPO26817 Lysionotus pauciflorus Species Gesneriaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO26817 Lysionotus pauciflorus Species Gesneriaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO26817 Lysionotus pauciflorus Species Gesneriaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO26817 Lysionotus pauciflorus Species Gesneriaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC579039 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7816 Intermediate Similarity NPC204693
0.7303 Intermediate Similarity NPC22062
0.7303 Intermediate Similarity NPC473634
0.7303 Intermediate Similarity NPC138811
0.6484 Remote Similarity NPC211594
0.6458 Remote Similarity NPC483707
0.6458 Remote Similarity NPC209296
0.6289 Remote Similarity NPC473623
0.6277 Remote Similarity NPC44931
0.6061 Remote Similarity NPC488089
0.6042 Remote Similarity NPC210073
0.5922 Remote Similarity NPC11468
0.5918 Remote Similarity NPC475366
0.5833 Remote Similarity NPC295613
0.5833 Remote Similarity NPC187379
0.5833 Remote Similarity NPC473657
0.5789 Remote Similarity NPC172807
0.5755 Remote Similarity NPC473644
0.5696 Remote Similarity NPC176775
0.5579 Remote Similarity NPC99957
0.5567 Remote Similarity NPC254540
0.5556 Remote Similarity NPC311850
0.55 Remote Similarity NPC473571
0.55 Remote Similarity NPC110941
0.549 Remote Similarity NPC473327
0.5484 Remote Similarity NPC186807
0.5446 Remote Similarity NPC46202
0.5446 Remote Similarity NPC126784
0.5446 Remote Similarity NPC241423
0.5435 Remote Similarity NPC58053
0.5405 Remote Similarity NPC68592
0.54 Remote Similarity NPC473512
0.54 Remote Similarity NPC129827
0.54 Remote Similarity NPC475155
0.5333 Remote Similarity NPC101636
0.53 Remote Similarity NPC67105
0.5243 Remote Similarity NPC470443
0.5238 Remote Similarity NPC475382
0.5238 Remote Similarity NPC473073
0.5196 Remote Similarity NPC186816
0.5158 Remote Similarity NPC181712
0.5149 Remote Similarity NPC173582
0.5149 Remote Similarity NPC15358
0.5149 Remote Similarity NPC265885
0.5149 Remote Similarity NPC181465
0.5149 Remote Similarity NPC215710
0.5149 Remote Similarity NPC473438
0.5149 Remote Similarity NPC227508
0.5149 Remote Similarity NPC253788
0.5146 Remote Similarity NPC284277
0.5146 Remote Similarity NPC475497
0.5133 Remote Similarity NPC488086
0.5128 Remote Similarity NPC262222
0.5098 Remote Similarity NPC203259
0.5098 Remote Similarity NPC65563
0.5098 Remote Similarity NPC33054
0.5098 Remote Similarity NPC470949
0.5098 Remote Similarity NPC176740
0.5098 Remote Similarity NPC471725
0.5098 Remote Similarity NPC134532
0.5098 Remote Similarity NPC602582
0.5094 Remote Similarity NPC476472
0.5094 Remote Similarity NPC294815
0.5094 Remote Similarity NPC16194
0.5089 Remote Similarity NPC488087
0.5057 Remote Similarity NPC469622
0.5056 Remote Similarity NPC479450
0.5053 Remote Similarity NPC95090
0.5053 Remote Similarity NPC27408
0.5049 Remote Similarity NPC257566

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC579039 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6458 Remote Similarity NPD7054 Phase 4
0.5769 Remote Similarity NPD7472 Pre-clinical
0.5098 Remote Similarity NPD6797 Phase 2
0.5046 Remote Similarity NPD7808 Phase 3

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data